Table 1. Comparison of baseline patient characteristics of patients undergoing EUS-GE and surgical GJ.
EUS-GE (n = 30) |
Surgical GJ
(n = 63) |
P value | |
Age (y), mean ± SD | 70 ± 13.3 | 68 ± 9.6 | 0.8 |
Sex, n (%) | |||
Male | 17 (57) | 32 (52) | 0.6 |
Female | 13 (43) | 31 (49) | |
Symptoms, n (%) | |||
Nausea | 23 (76) | 35 55) | 0.06 |
Vomiting | 17 (56) | 35 (55) | 1 |
Abdominal pain | 4 (13) | 41 (65) | < 0.001 |
Weight loss (Kg) | 28 (93) | 61 (98) | 0.6 |
Etiology, n (%) | |||
Gastric cancer | 5 (17.6) | 0 (0) | 0.002 |
Ampullary cancer | 2 (6.7) | 9 (14) | 0.49 |
Duodenal cancer | 0 (0) | 1 (1.5) | 0.9 |
Pancreatic cancer | 17 (56) | 53 (84.5) | 0.003 |
Biliary/gallbladder cancer | 2 (6.7) | 0 (0) | 0.1 |
Extrinsic/metastatic cancer | 4 (13) | 0 (0) | 0.009 |
Site of the obstruction, n (%) | |||
Pyloric/duodena bulb | 7 (23) | 2 (3) | 0.004 |
Second part of the duodenum | 15 (50) | 57 (90) | < 0.001 |
Distal duodenum/proximal jejunum | 8 (27) | 4 (7) | 0.01 |
Peritoneal Carcinomatosis, n (%) | 13 (43) | 7 (11) | < 0.001 |